Co. Ltd. has patented new tricyclic compounds acting as serine/threonine-protein kinase ATR inhibitors and thus reported to be useful for the treatment of colon cancer.
University of Eastern Finland, Kuopio, Finland. Tousled-like kinase 2 (TLK2) is a ubiquitously expressed, nuclear serine/threonine kinase. The kinase activity of TLK2 and its closest human ...
No writing assistance was utilized in the production of this manuscript. BRAF, a member of a serine/threonine kinase protein family, serves as an immediate downstream effector of RAS in the MAPK ...
uhnresearch.ca Objectives Mammalian target of rapamycin (mTOR) (a serine/threonine protein kinase) is a major repressor of autophagy, a cell survival mechanism. The specific in vivo mechanism of mTOR ...
RIPK1 – or receptor-interacting serine/threonine-protein kinase 1 – is thought to play a role in regulating the immune system, and has been a target for programmes both in inflammatory ...
§ p = 0.0001 between temsirolimus and IFN-α. ¶ p = 0.0001. # p = 0.0001. ** p = 0.001. NR: Not reported; ORR: Overall response rate; OS: Overall survival; PFS ...
Subsequent downstream analysis identified IGFBP3, ABCC6, ULK3, DOT1L, KLB, and AMH as promising candidates for drug repurposing. ULK3 is a serine/threonine protein kinase that functions as a pivotal ...